Publication | Closed Access

Conventional magnetic resonance imaging–based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas

Neuro-oncologyEngineeringGliomaMedicineGeneticsConventional Magnetic ResonanceRadiomic SignatureCancer GenomicsHigh-grade GliomasCancer GeneticsSystems BiologyMolecular DiagnosticsRadiation OncologyImaging GenomicsIii Gliomas